Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-920
Closed -$213K 35
2025
Q3
$213K Buy
+920
New +$187K 0.09% 36
2025
Q2
Sell
-1,067
Closed -$224K 36
2025
Q1
$224K Buy
+1,067
New +$207K 0.11% 36
2024
Q3
Sell
-1,424
Closed -$244K 36
2024
Q2
$244K Buy
1,424
+49
+4% +$8.12K 0.13% 39
2024
Q1
$250K Sell
1,375
-121
-8% -$20.9K 0.14% 41
2023
Q4
$232K Buy
1,496
+2
+0.1% +$292 0.14% 45
2023
Q3
$223K Sell
1,494
-1,000
-40% -$147K 0.16% 42
2023
Q2
$336K Buy
+2,494
New +$366K 0.24% 31
2023
Q1
Sell
-1,346
Closed -$218K 39
2022
Q4
$218K Buy
+1,346
New +$206K 0.19% 38

Other funds holding ABBV

Parker Financial's ABBV Position: Q4 2025 in Review

Parker Financial sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 920 shares — an estimated $213K sold.

Parker Financial first reported a position in ABBV in Q4 2022 and held it in 8 quarters. The position peaked at $336K in Q2 2023. 4,155 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • Parker Financial reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
  • Parker Financial sold 920 AbbVie shares in Q4 2025, an estimated $213K.
  • Parker Financial first reported a position in AbbVie in Q4 2022 and held it in 8 quarters.
  • Parker Financial's AbbVie position peaked at $336K in Q2 2023.
  • 4,155 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Parker Financial's 13F filing for Q4 2025, filed 3 Feb 2026.